HLA-C and neoplasm: TAAs derived from proto-oncogenes and genes overexpressed in the tumor microenvironment can be captured by tumor-infiltrated APCs (including pDCs), which transport them to the lymph nodes and process them into peptides that will be presented through MHC molecules to naïve T cells, thus initiating antitumor immune responses.